Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

The Eclipse Foundation's Jakarta EE Working Group has released Jakarta EE 11, the latest version of its enterprise Java platform, marking a significant step in modernizing enterprise Java development ...

Data structures contain two important aspects that computer scientists seek to verify: behavior and cost. The behavior of data structures has long been studied using abstraction functions, which ...

PDVSA launches Blend 22 exports ahead of May 27 license expiry New crude blend being shipped from Western La Salina port Vitol-chartered vessel's hull being cleaned after loading at La Salina Loading ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...

As an increasingly challenging development landscape forces data center providers and investors to get creative, a growing share of projects are being funded through massive joint venture partnerships ...

US data centers will need 55 gigawatts of new power capacity within the next five years, according to a report released this week by Bloom Energy. The report, based on a survey of 100 data center ...